Generating vesicular stomatitis virus pseudotype bearing the severe acute respiratory syndrome coronavirus spike envelope glycoprotein for rapid and safe neutralization test or cell-entry assay

Ann N Y Acad Sci. 2006 Oct;1081(1):246-8. doi: 10.1196/annals.1373.030.

Abstract

We generated a recombinant vesicular stomatitis virus (VSV) pseudotype (VSV Delta G*SG) by replacing the envelope G gene with the GFP gene and complementing with spike glycoprotein (S) of SARS-CoV in trans. The neutralization and infection blocking tests showed that the VSV Delta G*SG and SARS-CoV reacted similarly to SARS-CoV specific antiserum, suggesting the VSVDelta G*SG can be a safe replacement of the live SARS-CoV for neutralization test and cell-entry assay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chickens
  • Chlorocebus aethiops
  • Cytopathogenic Effect, Viral
  • Membrane Glycoproteins / immunology*
  • Neutralization Tests / standards
  • Neutralization Tests / veterinary
  • Rhabdoviridae Infections / immunology
  • Rhabdoviridae Infections / veterinary*
  • Safety
  • Severe acute respiratory syndrome-related coronavirus / immunology*
  • Specific Pathogen-Free Organisms
  • Spike Glycoprotein, Coronavirus
  • Vero Cells
  • Vesicular stomatitis Indiana virus / genetics
  • Vesicular stomatitis Indiana virus / immunology*
  • Viral Envelope Proteins / immunology*

Substances

  • Membrane Glycoproteins
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins